Personalized starting age of gastric cancer screening based on individuals' risk profiles: a population-based, prospective study

被引:1
|
作者
He, Siyi [1 ]
Zhang, Zhiyi [2 ]
Song, Guohui [3 ]
Wang, Zhenhai [4 ]
Li, He [5 ]
Cao, Maomao [1 ]
Yang, Fan [1 ]
Sun, Dianqin [1 ,6 ]
Yan, Xinxin [1 ]
Zhang, Shaoli [1 ]
Teng, Yi [1 ]
Li, Qianru [1 ]
Xia, Changfa [1 ]
Chen, Wanqing [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Off Canc Screening, Natl Clin Res Ctr Canc,Natl Canc Ctr, 17 Pan jia yuan South Lane, Chaoyang 100021, Peoples R China
[2] Gansu Wuwei Tumor Hosp, Dept Gastroenterol, Wuwei, Peoples R China
[3] Hosp Ci Cty, Dept Epidemiol, Canc Inst, Handan, Peoples R China
[4] Linzhou Canc Hosp, Dept Gen Surg, Linzhou, Peoples R China
[5] China Med Univ, Affiliated Hosp 1, Off Natl Canc Reg Med Ctr Liaoning Prov, Shenyang, Peoples R China
[6] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
来源
基金
中国国家自然科学基金;
关键词
CHINA; ESOPHAGUS; DYSPLASIA; MORTALITY; LINXIAN; TRENDS;
D O I
10.1093/jnci/djae162
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The current recommended starting age for gastric cancer screening lacks unified guideline and individualized criteria. We aimed to determine the risk-stratified starting age for gastric cancer screening in China based on individuals' risk profiles and to develop an online calculator for clinical application.Methods In this multicenter, population-based, prospective study, we allocated participants enrolled between 2015 and 2017 (N = 59 771, aged 40-69 years) to screened and unscreened groups and observed them for primary endpoints: gastric cancer occurrence as well as all-cause and gastric cancer-specific death. Median follow-up was 6.07 years. To determine the reference starting age, the effectiveness of gastric cancer screening was assessed by age group after propensity score matching. Further, we categorized the calculated individual risk scores (using well-established risk factors) by quantile. Subsequently, we used age-specific, 10-year cumulative risk curves to estimate the risk-stratified starting age-that is, when the individual's risk level matches the reference starting age risk threshold.Results During follow-up, 475 gastric cancer case patients, 182 gastric cancer-related deaths, and 1860 all-cause deaths occurred. All-cause and gastric cancer-specific mortality decreased among screened individuals 45 years of age and older and 50 to 59 years of age, respectively. Thus, the average population (referent) starting age was set as 50 years. The 10-year cumulative risk of gastric cancer in the average population aged 50 years was 1.147%. We stratified the starting age using 8 risk factors and categorized participants as low-risk, medium-risk, and high-risk individuals whose risk-stratified starting age was 58, 50, and 46 years, respectively.Conclusion Although high-risk individuals warrant starting gastric cancer screening 3 to 5 years earlier than for the average population (aged 50 years), low-risk individuals can tolerate delayed screening. Our online, personalized starting age calculator will help with risk-adapted gastric cancer screening (https://web.consultech.com.cn/gastric/#/).
引用
收藏
页码:1775 / 1783
页数:9
相关论文
共 50 条
  • [41] Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
    A H Poulsen
    S Christensen
    J K McLaughlin
    R W Thomsen
    H T Sørensen
    J H Olsen
    S Friis
    British Journal of Cancer, 2009, 100 : 1503 - 1507
  • [42] Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR
    Hoffmann, Sabine
    Crispin, Alexander
    Lindoerfer, Doris
    Sroczynski, Gaby
    Siebert, Uwe
    Mansmann, Ulrich
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [43] Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR
    Sabine Hoffmann
    Alexander Crispin
    Doris Lindoerfer
    Gaby Sroczynski
    Uwe Siebert
    Ulrich Mansmann
    FARKOR Consortium
    BMC Gastroenterology, 20
  • [44] Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan
    Yu-Chen Chang
    Chien-Ju Lin
    Tzu-Lin Yeh
    Ming-Chieh Tsai
    Le-Yin Hsu
    Kuo-Liong Chien
    Hsin-Yin Hsu
    Lipids in Health and Disease, 20
  • [45] Cardiorespiratory fitness and lung cancer risk: A prospective population-based cohort study
    Pletnikoff, Perfenia Paul
    Tuomainen, Tomi-Pekka
    Laukkanen, Jari A.
    Kauhanen, Jussi
    Rauramaa, Rainer
    Ronkainen, Kimmo
    Kurl, Sudhir
    JOURNAL OF SCIENCE AND MEDICINE IN SPORT, 2016, 19 (02) : 98 - 102
  • [46] Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study
    Xia, Bin
    He, Qiangsheng
    Pan, Yihang
    Gao, Fang
    Liu, Anran
    Tang, Yan
    Chong, Charing
    Teoh, Anthony Y. B.
    Li, Fangping
    He, Yulong
    Zhang, Changhua
    Yuan, Jinqiu
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (12) : 3384 - 3393
  • [47] Physical activity and risk of endometrial cancer: A population-based prospective cohort study
    Friberg, Emilie
    Mantzoros, Christos S.
    Wolk, Alicja
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (11) : 2136 - 2140
  • [48] Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk
    Chen, Xuechen
    Heisser, Thomas
    Cardoso, Rafael
    Hoffmeister, Michael
    Brenner, Hermann
    JAMA NETWORK OPEN, 2023, 6 (10) : E2339670
  • [49] Family history of gastric mucosal abnormality and the risk of gastric cancer: a population-based observational study
    Song, Huan
    Ekheden, Isabella Guncha
    Ploner, Alexander
    Ericsson, Jan
    Nyren, Olof
    Ye, Weimin
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (02) : 440 - 449
  • [50] Suicide in patients with gastric cancer: a population-based study
    Sugawara, Akitomo
    Kunieda, Etsuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (09) : 850 - 855